GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Inventories, Finished Goods

Genome (XKRX:314130) Inventories, Finished Goods : ₩3,770 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genome Inventories, Finished Goods?

Genome's quarterly finished goods increased from Jun. 2024 (₩3,200 Mil) to Sep. 2024 (₩3,915 Mil) but then declined from Sep. 2024 (₩3,915 Mil) to Dec. 2024 (₩3,770 Mil).

Genome's annual finished goods increased from Dec. 2022 (₩1,326 Mil) to Dec. 2023 (₩2,213 Mil) and increased from Dec. 2023 (₩2,213 Mil) to Dec. 2024 (₩3,770 Mil).

Genome Inventories, Finished Goods Historical Data

The historical data trend for Genome's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Inventories, Finished Goods Chart

Genome Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial - 858.30 1,326.22 2,212.74 3,769.57

Genome Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,212.74 2,151.96 3,200.48 3,914.52 3,769.57

Genome Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Genome Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Inventories, Finished Goods
Comparable Companies
XKRX:067370 XKRX:049960 XKRX:185490 XKRX:046210 XKRX:383930 XKRX:388870 XKRX:378800 XKRX:261780 XKRX:365270 XKRX:348080 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Website
http://www.genomecom.co.kr
Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome Headlines

No Headlines